Bavarian Nordic bolstered its cash reserves with a $160m sale of a priority review voucher in June 2025. The company has now ...

This webinar offers essential tools and insights to help organisations confidently navigate the BioSecure Act, ensuring they ...

Gilead will integrate Interius, the first biotech to push an in vivo CAR-T therapy into the clinic, into its cell therapy ...

The FDA has granted approval for Ionis Pharmaceuticals’ Dawnzera (donidalorsen), for use in preventing hereditary angioedema ...

Antibody‑drug conjugates (ADCs) remain an area of extreme focus in the pharmaceuticals space, with the market projected to ...

Andelyn Biosciences has entered into a collaboration with Amplo Biotechnology for manufacturing AAV gene therapies.

Padcev-Keytruda will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.

The upcoming Clinical Trials in Rare Diseases conference will cover the most concerning challenges in rare disease research.